Table 2 Age-adjusted and age group-specific 5-year relative survival (RS) for the period 2002-2006 by histologic subtypes of endometrial cancer patients diagnosed in Germany, 1997-2006^a

Overall

30,906 (100)

81.0 (0.4)

1,949 (6)

90.0 (1.0)

15,995 (52)

84.8 (0.4)

12,962 (42)

74.8 (0.8)

Adenocarcinoma

28,273 (91.5)

83.9 (0.4)

1,578 (6)

92.6 (1.0)

14,748 (52)

87.6 (0.4)

11,947 (42)

77.8 (0.8)

   Adenocarcinoma, NOS

10,427 (33.7)

84.7 (0.7)

606 (6)

93.5 (1.5)

5,353 (51)

88.7 (0.7)

4,468 (43)

78.1 (1.3)

   Papillary

1,141 (3.7)

68.4 (2.4)

50 (4)

547 (48)

77.2 (2.7)

544 (48)

57.3 (3.8)

   Clear cell

330 (1.1)

62.0 (4.3)

8 (2)

140 (43)

182 (55)

   Squamous metaplasia

686 (2.2)

94.3 (2.5)

65 (9)

95.2 (3.9)

375 (55)

92.3 (2.4)

246 (36)

94.1 (4.9)

   Mucinous

268 (0.9)

85.2 (4.1)

12 (5)

130 (48)

93.4 (3.9)

126 (47)

   Adenosquamous

857 (2.8)

75.0 (2.5)

57 (7)

453 (53)

80.1 (2.9)

347 (40)

64.3 (4.8)

   Endometrioid

13,650 (44.2)

86.0 (0.7)

738 (5)

93.7 (1.4)

7,323 (54)

88.8 (0.6)

5,589 (41)

81.3 (1.3)

   Other adenocarcinoma^d

914 (2.9)

68.3 (2.5)

42 (4)

427 (47)

70.5 (3.3)

445 (49)

57.2 (4.4)

Carcinoma NOS

619 (2.0)

60.4 (3.3)

42 (7)

272 (44)

69.1 (4.4)

305 (49)

Sarcoma

1,682 (5.4)

43.1 (1.8)

287 (17)

75.7 (3.8)

834 (50)

47.6 (2.4)

561 (33)

31.7 (3.3)

Others (mixture) ^e

332 (1.1)

47.3 (4.2)

42 (13)

141 (42)

149 (45)